← All stocks

Cyclerion Therapeutics, Inc.

CYCN No buying or selling
CIK 0001755237 #5052 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

5 insiders · 2 transactions

There is no salary here to measure against. Cyclerion Therapeutics, Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hecht Peter M
Director
910,240
19.44%
$1.41M
+141.2%
Graul Regina Margaret
See Remarks
107,523
2.30%
$166.78K
+7.2%
Higgins Michael J
Director
30,740
0.6566%
$47.68K
+42.0%
CHICKO RHONDA M.
Chief Financial Officer
25,018
0.5344%
$38.81K
+138,889%
Slate Path Capital LP entity
10% owner
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
Graul Regina Margaret
14 Aug 2026
See Remarks
Exercised, kept
55,849
$3.30
$184.30K
CHICKO RHONDA M.
14 Aug 2026
Chief Financial Officer
Exercised, kept
25,000
$2.36
$58.88K

What was left out

Form 4 filings counted 7
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 480,515
History held since 2 Apr 2019